title: Osteoma of the calvaria in L-2-hydroxyglutaric aciduria.
abstract: L-2-Hydroxyglutaric aciduria (L-2-OHGA) is a rare autosomal recessive neurometabolic disease linked to chromosome 14q21.1 and is caused by mutations in the gene that most likely encodes L: -2-hydroxyglutarate dehydrogenase, which normally catalyses L: -2-hydroxyglutarate to alpha-ketoglutarate. It is characterized by progressive mental deterioration, pyramidal and cerebellar syndromes, macrocephaly and marked polycystic white-matter degeneration mainly involving frontal lobes. Brain tumours of variable nature have frequently been observed in L-2-OHGA. We report a patient affected by this disease who at the age of 20 years developed a bone tumour involving the right frontal region of the calvaria. He had first presented at the age of 10 years with psychomotor delay, clumsy gait and moderate mental impairment. Examination showed macrocephaly, cerebellar ataxia and quadripyramidal syndrome. Brain MRI showed low signal intensities on T1-weighted images and high signal intensities on T2-weighted images in cerebral subcortical white matter. Serum and urinary amino acid assay was normal. Urinary 2-hydroxyglutaric acid was 1418 mmol/mol creatinine (controls <25). Analysis of the L-2-hydroxyglutarate dehydrogenase gene revealed a homozygous mutation in exon 2 (A320G). At the age of 20 years, an osteoma of the right frontal bone was diagnosed. This finding reinforces the opinion concerning the association of L-2-OHGA and tumorigenesis and prompted us to verify the possible responsibility of some overproduced substances in this disease for the development of tumours and to look for any correlation between the type of mutation in the L-2-OHGA gene and the tumorigenic potential observed in some patients affected by this disease.
authors.affiliation: Institut National de Neurologie, Hôpital la Rabta, Tunis, Tunisia. abdelmajid.larnaout@rns.tn
authors.forename: A
authors.initials: A
authors.lastname: Larnaout
authors.forename: R
authors.initials: R
authors.lastname: Amouri
authors.forename: S
authors.initials: S
authors.lastname: Neji
authors.forename: M
authors.initials: M
authors.lastname: Zouari
authors.forename: N
authors.initials: N
authors.lastname: Kaabachi
authors.forename: F
authors.initials: F
authors.lastname: Hentati
mesh_terms: D000328:Adult; D001859:Bone Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000235:genetics / Q000473:pathology*; D001921:Brain / Q000473:pathology; D020739:Brain Diseases, Metabolic, Inborn / Q000150:complications* / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000652:urine; D003404:Creatinine / Q000378:metabolism; D015140:Dementia, Vascular / Q000175:diagnosis; D005977:Glutarates / Q000378:metabolism*; D006720:Homozygote; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009154:Mutation; D010016:Osteoma / Q000150:complications* / Q000175:diagnosis / Q000235:genetics / Q000473:pathology*; D013577:Syndrome
chemical_list: D005977:Glutarates; C019417:alpha-hydroxyglutarate; D003404:Creatinine